EUVIMEDEUVIMED entdecken
Crossref

Multimodal supramolecular targeting chimeras enable spatiotemporally resolved protein degradation in vivo

Ji Liu, Tianyu Ma, Rui Yao, Lijuan Li, Qizhen Zheng, Ming Wang

Cell · 2026-02 · 189 (4) · 1108-1123.e20

DOI: 10.1016/j.cell.2025.12.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2026-02. Verfasst von Ji Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese…. Hauptthemen laut MEDLINE: Proteolysis. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Beijing National Laboratory for Molecular Sciences, Beijing Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation (TPD) has transformed strategies for modulating protein function in both basic biology and therapeutic development. However, current strategies often lack the spatial and temporal precision required for in vivo applications. Herein, we report supramolecular targeting chimeras (SupTACs), a modular and programmable platform that enables tissue-specific and temporally controlled protein degradation in vivo. SupTACs self-assemble into supramolecular nanoparticles (SNPs) that co-localize target-binding ligands and E3 ligase recruiters, thereby facilitating proteasomal degradation through multivalent supramolecular proximity. This strategy achieves robust and tissue-specific degradation, including liver and lung specificity, in multiple species up to non-human primates. As a proof of concept, lung-specific degradation of acyl-coenzyme A (CoA) synthetase long-chain family member 4 (ACSL4) using SupTACs effectively mitigates ferroptosis and pulmonary inflammation in a murine model of acute lung injury. By integrating modularity, tissue specificity, and temporal regulation, SupTACs establish a versatile platform for precise control of protein degradation for interrogating dynamic signaling networks and developing targeted therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteolysisAnimalsNanoparticlesHumansMiceCoenzyme A LigasesProteasome Endopeptidase ComplexLungProteolysis Targeting ChimeraUbiquitin-Protein LigasesMice, Inbred C57BLLiver

Stichwörter der Autor:innen

PROTACbio-orthogonal activationdeliveryferroptosisin vivo protein degradationlung inflammationspatiotemporalsupramolecular nanoparticlestargeted protein degradationtissue specific

Substanzen

Coenzyme A LigasesProteasome Endopeptidase ComplexProteolysis Targeting ChimeraUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Beijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Aca…

Förderung

  • Beijing National Laboratory for Molecular Sciences
  • Beijing Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Liu, J., Ma, T., Yao, R., Li, L., Zheng, Q., & Wang, M. (2026). Multimodal supramolecular targeting chimeras enable spatiotemporally resolved protein degradation in vivo. Cell, 189(4), 1108-1123.e20. https://doi.org/10.1016/j.cell.2025.12.007

Vancouver

Liu J, Ma T, Yao R, Li L, Zheng Q, Wang M. Multimodal supramolecular targeting chimeras enable spatiotemporally resolved protein degradation in vivo. Cell. 2026;189(4):1108-1123.e20. doi:10.1016/j.cell.2025.12.007

BibTeX
@article{Liu2026,
  author = {Liu, Ji and Ma, Tianyu and Yao, Rui and Li, Lijuan and Zheng, Qizhen and Wang, Ming},
  title = {Multimodal supramolecular targeting chimeras enable spatiotemporally resolved protein degradation in vivo},
  journal = {Cell},
  year = {2026},
  volume = {189},
  number = {4},
  pages = {1108--1123.e20},
  doi = {10.1016/j.cell.2025.12.007}
}
Kostenlos starten →